首页 | 本学科首页   官方微博 | 高级检索  
     


Fenestrated/branched endovascular aortic repair using unilateral femoral access in patients with iliac occlusive disease
Affiliation:1. Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN;2. Division of Vascular Surgery, Maastricht University Medical Center, Maastricht, the Netherlands;3. Department of Cardiothoracic and Vascular Surgery, University of Texas Health Science Center at Houston, Houston, TX;1. Department of Vascular Surgery, Maasstad Hospital, Rotterdam, the Netherlands;2. Department of Interventional Radiology, Maasstad Hospital, Rotterdam, the Netherlands;3. Department of Interventional Radiology, St. Antonius Hospital, Nieuwegein, the Netherlands;4. Department of Surgery, Division of Vascular Surgery, University Medical Centre, Groningen, the Netherlands;5. Department of Vascular Surgery, St. Antonius Hospital, Nieuwegein, the Netherlands;6. Department of Vascular Surgery, Rijnstate Hospital, Arnhem, the Netherlands;7. Department of Vascular Surgery, University Medical Centre Utrecht, Utrecht, the Netherlands;8. Department of Vascular Surgery, Isala Clinics, Zwolle, the Netherlands;9. Department of Vascular Surgery, Meander Medical Centre, Amersfoort, the Netherlands;10. Department of Vascular Surgery, Catharina Hospital, Eindhoven, the Netherlands;1. Department of Vascular Surgery, University Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece;2. German Aortic Center, Department of Vascular Medicine, University Heart & Vascular Center Hamburg, Hamburg, Germany;1. Groupe Européen de Recherche sur les Prothèses Appliquées à la Chirurgie Vasculaire (GEPROVAS), Strasbourg, France;2. Department of Vascular Surgery, Henri Mondor Hospital, Assistance Publique – Hôpitaux de Paris (AP-HP), Créteil, France;3. Laboratoire de Physique et Mécanique Textiles (LPMT), ENSISA, Mulhouse, France;4. Department of Vascular Surgery and Kidney Transplantation, Hôpitaux Universitaires de Strasbourg, Université de Strasbourg, Strasbourg, France;5. UMR 1018, Inserm-Paris11 - CESP, Versailles Saint-Quentin-en-Yvelines University, Paris-Saclay University, Paul Brousse Hospital, Villejuif, France;6. Department of Vascular Surgery, Ambroise Paré University Hospital, Assistance Publique – Hôpitaux de Paris (AP-HP), Boulogne-Billancourt, and Faculté de Médecine Paris-Ile de France-Ouest, UFR des sciences de la santé Simone Veil, Université Versailles Saint-Quentin en Yvelines, Montigny-le-Bretonneux, France
Abstract:ObjectiveFenestrated/branched endovascular aortic repair (F/BEVAR) in patients with occluded iliac arteries is challenging owing to limited access for branch vessel catheterization and increased risk for leg and spinal ischemic complications. The aim of this study was to analyze technical strategies and outcomes of F/BEVAR in patients with unilateral iliofemoral occlusive disease.MethodsWe performed a retrospective review of all consecutive patients treated by F/BEVAR in two institutions (2003-2021). Patients with unilateral iliofemoral occlusive disease were included in the analysis. All patients had one patent iliac artery that was used for advancement of the fenestrated-branch component. Preloaded catheter/guidewire systems or steerable sheaths were used as adjuncts to facilitate catheterization. Primary endpoints were technical success, mortality, major adverse events (stroke, spinal cord injury, dialysis or decrease in the glomerular filtration rate of more than 50%, bowel ischemia, myocardial infarction, or respiratory failure), primary iliac patency, and freedom from reinterventions.ResultsThere were 959 patients treated with F/BEVAR. Of these, 15 patients (1.56%; mean age, 74 years; 80% male) had occluded iliac arteries and 1 patent iliofemoral access and were treated for a thoracoabdominal aortic aneurysm (n = 8) or juxtarenal abdominal aortic aneurysm (n = 7). Brachial access was used in 14 of the 15 patients and preloaded systems in 7 of the 15 patients (47%). The remaining 53% had staggered deployment of stent grafts. There were seven physician-modified endovascular grafts, seven custom-made devices, and one off-the-shelf device used. Thirteen patients (87%) had distal seal using aortouni-iliac stent grafts and two (13%) had distal seal in the infrarenal aorta. Concomitant femoral crossover bypass (FCB) was performed in two patients and six patients had a prior FCB. Technical success was 100%. There were no intraoperative complications or early lower extremity ischemic complications, and all FCB were preserved. There was one mortality (7%) within 30 days owing to retrograde type A dissection. Major adverse events occurred in 20% of patients. The median follow-up was 12 months (range, 0-85 months). Two patients (13%) required three reinterventions. One patient required proximal stent graft extension for an acute type B dissection (3 months) and another required iliac extension for type Ib endoleak of an aortouni-iliac graft (21 months) and thrombolysis of that extension (50 months). At last follow-up, all patients had primary graft patency except one with secondary graft patency without new claudication. One patient had a single renal artery stent occlusion at follow-up with no r-intervention. The overall survival rate was 60%, without aortic-related deaths.ConclusionsAlthough challenging, F/BEVAR with unilateral femoral/brachial approach is feasible in patients with occluded iliac limbs, with an important rate of ischemic complications, but satisfactory outcomes.
Keywords:Thoracoabdominal aortic aneurysm  Juxtarenal abdominal aortic aneurysm  Iliac occlusion
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号